Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates
PLOS Computational Biology · 2026
DOI: 10.1371/journal.pcbi.1014715 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2026. Verfasst von Billy J Quilty und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom. Hauptthemen laut MEDLINE: Viral Load, COVID-19, SARS-CoV-2. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Bill & Melinda Gates Foundation.
Abstract (Originalsprache)
SARS-CoV-2 transmission is highly overdispersed, with a minority of individuals responsible for the majority of transmission, though the drivers of this heterogeneity are unclear. Here, we assess the contribution of variation in viral load and daily contact rates to this heterogeneity by combining published viral load estimates and contact survey data in a mathematical model to estimate the secondary infection distribution. Using data from the BBC Pandemic and CoMix contact surveys, we estimate the secondary infection distribution throughout the pandemic in the UK in 2020, and the effectiveness of frequent and pre-event rapid testing for reducing superspreading events. We find that individual heterogeneity in contacts rather than individual heterogeneity in shedding is the main driver of observed heterogeneity in the secondary infection distribution. Our results suggest that everyone testing every 3 days would reduce the reproduction number below 1 and be equivalent in terms of impact on secondary infections to everyone testing only before events with a minimum event size of 10 for pre-pandemic contact levels. This work demonstrates the potential for using viral load and contact data to estimate heterogeneity in transmission and the effectiveness of rapid testing strategies for curbing transmission in future pandemics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Centre for Mathematical Modelling of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.
- Center for Global Health, Charité Universitatsmedizin Berlin, Berlin, Germany.
- School of Mathematical Sciences, Lancaster University, Lancaster, United Kingdom.
- Department of Biosystems Science and Engineering, ETH Zurich, Basel, Switzerland.
- Department of Infectious Diseases, School of Immunology and Microbial Sciences, King's College London, London, United Kingdom.
ORCID-Profile: Lloyd A C Chapman, Amy Gimma
Förderung
- Wellcome Trust
- Medical Research Council
- Bill & Melinda Gates Foundation
- European Commission
- National Institute for Health and Care Research
- Bill and Melinda Gates Foundation
- National Institute for Health Research Health Protection Research Unit
- Huo Family Foundation
Zitieren
APA
Quilty, B. J., Chapman, L. A. C., Munday, J. D., Wong, K. L. M., Gimma, A., Pickering, S., Neil, S., Galao, R. P., Edmunds, W. J., Jarvis, C. I., & Kucharski, A. J. (2026). Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1014715
Vancouver
Quilty BJ, Chapman LAC, Munday JD, Wong KLM, Gimma A, Pickering S, et al. Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates. PLOS Computational Biology. 2026. doi:10.1371/journal.pcbi.1014715
BibTeX
@article{Quilty2026,
author = {Quilty, Billy J and Chapman, Lloyd A C and Munday, James D and Wong, Kerry L M and Gimma, Amy and Pickering, Suzanne and Neil, Stuart and Galao, Rui Pedro and Edmunds, W John and Jarvis, Christopher I and Kucharski, Adam J},
title = {Disentangling the drivers of heterogeneity in SARS-CoV-2 transmission from data on viral load and daily contact rates},
journal = {PLOS Computational Biology},
year = {2026},
doi = {10.1371/journal.pcbi.1014715}
}
EUVIMED